ETG ŁÓDŹ
- Address
- Stanisława Wigury 19, 90-302 Lodz, Poland
ETG ŁÓDŹ - Respiratory Disease Research Center
ETG ŁÓDŹ is a clinical research facility dedicated to advancing the understanding and treatment of respiratory diseases. The center specializes in conducting pivotal trials that evaluate innovative therapeutic approaches for patients suffering from chronic respiratory conditions, with a particular focus on improving patient outcomes and quality of life.
- Chronic Obstructive Pulmonary Disease (COPD) exacerbation prevention studies
- Novel biologic therapies and targeted immunomodulatory agents
- Long-term efficacy and safety evaluations in respiratory medicine
The center's research portfolio includes comprehensive investigations of astegolimab and other emerging biologics designed to reduce acute exacerbations of COPD. With expertise in conducting year-long treatment studies, ETG ŁÓDŹ plays a vital role in evaluating next-generation therapies that aim to modify disease progression and reduce the burden of chronic respiratory disease on patients and healthcare systems.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ETG ŁÓDŹ
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Astegolimab in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study | Genentech Inc. | Phase II | Not Recruiting | Jan 2022 | Feb 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Betula Pollen Extract | 1 | Unknown | 2023-09-20 | 2023-09-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.